Introduction
Members of the myc family of nuclear proto-oncogenes (c-, N-, and L-myc) play central roles in the control of normal growth and development and in genetic pathways linked to cellular transformation and apoptotic cell death (Evan and Littlewood, 1993; Morgenbesser and DePinho, 1994) . Accumulating structural, biochemical, and genetic evidence affords the view that the function of Myc family oncoproteins in these diverse processes relates in part to their roles as sequence-specific transcription factors (for reviews see Torres et al., 1992) . Myc family oncoproteins appear to influence the expression of growth-promoting genes, such as those involved in DNA synthesis (Bello-Fernandez et al., 1993) and cell cycle regulation (Jansen-Durr et al., 1993) , in a positive manner. Myc may also play a repressive role in the regulation of some genes through interaction with an initiation factor of the general transcriptional machinery (Roy et al., 1993) .
Myc family proteins possess a multifunctional aminoterminal domain with transactivation potential (Kato et al., 1990) , a region rich in basic amino acid residues responsible for sequence-specific DNA-binding activity (Blackwell *The first two authors contributed equally to this work. et al., 1990) , and a carboxy-terminal a-helical domain required for dimerization with another basic region-helixIoop-helix-leucine zipper (bHLH-LZ) protein, Max (Blackwood and Eisenman, 1991; Prendergast et al., 1991) . Many of the biochemical and biological activities of Myc appear to be highly dependent upon its association with Max (Blackwood and Eisenman, 1991 ; Prendergast et al., 1991; Kretzner et al., 1992; Amati et al., 1993a Amati et al., , 1993b . In addition to its key role as an obligate partner in transactivation-competent Myc-Max complexes, Max may also repress Myc-responsive genes through the formation of transactivation-inert complexes that are capable of binding the Myc-Max recognition sequence Kretzner et al., 1992; Makela et al., 1992; Mukherjee et al., 1992; Prendergast et al., 1992; Zervos et al., 1993) . These complexes include Max-Max homodimers, whose DNA-binding activity is subject to regulation by casein kinase II phosphorylation (Berberich and Cole, 1992) , and the recently described heterodimers Mad-Max and Mxil-Max (Zervos et al., 1993) . Together, these functionally interactive and structurally related bHLH-LZ proteins comprise an expanding Myc superfamily.
The biochemical properties of the highly homologous MAD and MXll have led to a model for their regulation of Myc activity in which these two proteins compete with Myc for binding both to Max and to common target sequences Zervos et al., 1993) . As such, the relative intracellular levels of Mad and Mxil in comparison to those of Myc influence the transcriptional activation of Mycresponsive genes through a dynamic interchange between the formation of transactivation-inert (Mad-Max or Mxil-Max) and transactivation-competent (Myc-Max) complexes Zervos et al., 1993) . The opposing relationship between Myc and Mad or Mxil derives further support from biological studies demonstrating that, during the approach of many cell lineages to the terminally differentiated state, MXl and MAD mRNA and protein levels increase, while those of c-MYC decrease Zervos et al., 1993; Larsson et al., 1994; Schreiber-Agus et al., 1994) , and that overexpression of MXll and MAD can antagonize myc activity in cellular transformation assays (Lahoz et al., 1994) . The anti-oncogenic activity of Mad and Mxil acquires particular significance with the localization of MAD and MXI1 genes to chromosomal loci implicated in the genesis of several human cancers (Edelhoff et al., 1994; M. F. Seldin and R. A. D., unpublished data) .
Progress on the elucidation of the precise molecular actions of Myc at the level of Myc-responsive gene targets and on the relation of such actions to growth and differentiation has been hampered by the modest transactivation activity of Myc in available transcription reporter assays and by the limited repertoire of bona fide myc gene targets. As an alternative strategy to understanding the nature of the actions of Myc and of the functional relationships among members of the Myc superfamily, we and others have used the rat embryo fibroblast (REF) cooperation assay (Land et al., 1983) . This highly quantitative biological assay takes advantage of a long-recognized property of Myc, namely, its ability to cooperate with activated H-RAS (Val-12) to effect the malignant transformation of earlypassage REFs. The REF cooperation assay has proven effective in the evaluation of candidate modulators of myc oncogenic potential, including the Max-associated proteins MAD and MXll (Lahoz et al., 1994) , dominant negative mutants of Myc (Mukherjee et al., 1992; Sawyers et al., 1992) , retinoblastoma (Rb), and other cell cycle regulators (Serrano et al., 1995) . The functional impact of such modulators correlates well with their biochemical profiles and postulated mechanisms of action. For instance, Rb, which is thought to interact poorly with Myc in vivo, has a minimal suppressive effect on myclRAS-induced foci formation (E. G. Lahoz and R. A. D., unpublished data) , while overexpression of MAD or MXl leads to a profound reduction in transformation activity in a highly Myc-specific manner (Lahoz et al., 1994) .
In the course of investigating the basis of the antioncogenic activity of Mxil, we identified two mxil mRNAs that arise through alternative RNA processing and that encode proteins with dramatically different abilities to repress myc-induced transformation. The capacity for strong repressive activity correlates with an amino-terminal extension of 36 residues that is present in only one of the two Mxi protein forms. Significantly, use of the yeast twohybrid interaction system showed that this highly conserved (z-helical "repression" domain of Mxil (and MAD) associates with a murine homolog of the yeast transcriptional repressor SIN3 (Nasmyth et al., 1987; Sternberg et al., 1987; Strich et al., 1989; Wang et al., 1990; Vidal et al., 1991; Wang and Stillman, 1993) . Through coimmunoprecipitation studies in mammalian cells, Mxil and mouse Sin3 (roSin3) were shown to be part of a ternary complex that also included Max. As such, the antagonistic activity of Mxi may be executed not only through its competition with Myc for Max and common gene targets but, more importantly, through its association with a transcriptional repressor.
Results

Key Structural Features of Mouse mxil Transcripts and Putative Proteins Alternative Transcript Forms of the Mouse taxi1 Gene Possess Overlapping Open Reading Frames That Encode Mxil Proteins with Different Amino Termini
Low stringency hybridization to mouse cDNA libraries employing several human MXI1 probes resulted in the isolation of two different cDNA clones, lmxi-SR and tmxi-WR, that differ only in their 5' regions. As shown below, the putative proteins encoded by these two cDNAs have very different abilities to antagonize the transformation activity of Myc, hence the designations SR and WR for strong repressor and weak repressor, respectively. The organization of mouse genomic sequences encoding the 5' regions of the mxi-SR and mxi-WR cDNAs is consistent with the existence of a single mxil gene capable of producing the two mRNAs through alternative RNA processing (N. S.-A., H.-W. Lee, and R. A. D., unpublished data).
Nucleic acid sequence analysis of the tmxi-SR cDNA clone revealed an ATG-initiated open reading frame (ORF) capable of encoding a protein of 228 amino acids with a predicted molecular size of 25,977 Da (Mxi-SR in Figure  1A ). That the predicted Mxi-SR protein indeed represents the mouse homolog of human MXll (Zervos et al., 1993 ; the human MXl clone was shown to be equivalent to mouse mxi-SR and not mouse mxi-WR) is supported by their shared amino acid identity of 96% compared with only 61% when aligned with human MAD . The second mxil cDNA clone, tmxi-WR, is identical to tmxi-SR in the nucleic acid sequences encoding residues 37-228 of the tmxi-SR ORF and in its 3' untranslated region (3'UTR). However, the 5'-most sequences of the tmxi-SR ORF are absent from tmxi-WR and are replaced by different sequences that do not encode an in-frame ORF. As a result, the putative protein encoded by tmxi-WR would likely initiate translation at an ATG that corresponds to a methionine at position 37 in the Mxi-SR protein (Mxi-WR in Figure 1A ). The Mxi.SR Amino.Terminal Extension While mxi-SR and mxi-WR ORFs encode identical bHLH-LZ and carboxy-terminal regions, alternative utilization of 5' sequences extends the mxil-SR ORF an additional 36 amino acids beyond the mxil-WR ORF. This extension is highly conserved throughout vertebrate evolution, exhibiting 100% similarity with human MXI 1 (Zervos et al., 1993) and 72% similarity with zebra fish Mxil (Schreiber-Agus et al., 1994) ( Figure 1B ; zebra fish not shown). Notably, this region is also highly homologous (78% similar) to an analogously positioned domain in human MAD (Figure 1 B) . The secondary structure of this Mxil-SR amino-terminal extension is predicted to be strongly (z-helical, and the potential for (~ helicity is conserved in the human MXI, human MAD, and zebra fish Mxi amino-terminal regions as well.
Mxi-SR and Mxi-WR Have Very Different Abilities to Repress Myc Transformation Activity
We demonstrated previously that human MXI1 and MAD are potent inhibitors of myc/RAS cotransformation of REFs; this effect was shown to be Myc specific (Lahoz et al., 1994) . In the present study, the quantitative nature of this biological assay was exploited to determine whether mxil-SR and mxil-WR differed in their inhibitory activities. Inhibition was assessed by comparing the number of transformed foci generated in cotransfections containing mouse c-myc and activated H-RAS in the presence or absence of an equimolar amount of various mxil expression constructs in multiple independent experiments (Figure 2 ).
In the first series of cotransfections, the mouse mxi-WR, mouse mxi-SR, and human MXI1 expression constructs were compared for their ability to repress c-myc/RAS oncogenic activity. The human MXI10RF used here was equivalent to the mouse mxil-SR form. As tabulated in Figure  2B (experiments 1, 4, and 5), a significant reduction in the number of foci generated was observed when either mouse mxi-SR or human MXI1 was added to the c-myc/ (Zervos et al., 1993) ORF sequences. Amino acid sequences (in single-letter code) were aligned using the Pileup program of the Genetics Computer Group sequence analysis software package (Devereux et al., 1984) . Position 1 is assigned to the putative initiation codon in the mouse Mxil-SR protein, and dashes represent: residues in mouse Mxi-WR or human MXl that are identical to the mouse Mxil-SR residues. The basic region is enclosed by a box, the two helices of the HLH region are stippled, and conserved hydrophobic residues of the 17 region are marked by open inverted triangles. With respect to the Mxil basic region, arrows indicate residues that have been shown crystallographically for Max (Ferre-D'Amare et al., 1993) and by site-directed mutagenesis for E box-binding proteins (Fisher :et al., 1993 , and references therein) to confer sequence-specific DNA recognition. The conservation of Glu-76 and Arg-80 in mouse Mxi-SR is integral, as these residues have been determined to contact the CG dinucleotide core of the E box specifically and thus serve to discriminate among the various CANNTG sequences. Residues that have been hypothesized to govern the selection or dismissal of dimerization partners are marked by asterisks. Specifically, the residues Arg-89 on helix 1, Lys-113 on helix 2, and Glu-123 and G lu-136 on the LZ are predicted to lie along the interacting electrostatic surface, a pred ct on based on the Max crystal structure (Ferre-D'Amare et ai., 1993) and modeling comparisons of the various Mxil proteins . The amino acid sequence of human MXI1 was derived from our correction of its published nucleic acid sequence (replacement of CG residues at positions 293-294 w th GGC, inversion of CG residues at positions 389-390, and deletion of TA residues at post ons 894-895 of the published human MXll cDNA sequence [Zervos et al., 1993 ; see also erratum of paper as listed in References]).
(B) Schematic maps of mouse Mxi-SR, mouse Mxi-WR, human MXl, and human MAD proteins are shown, with landmark regions indicated (closed box shows repressive region). Amino acid sequences were aligned as in (A) with dashes representing residues identical to the mouse Mxil-SR residues and dots in the sequence representing gaps that were introduced to maximize homology. Shown here is an align-RAS cotransfections; this level of suppression was comparable to that reported previously for the human MXll gene (Lahoz et al., 1994 Figure 2B ). Conversely, when sequences encoding the 36 residues of this domain of human MXll were appended to the ORF of mouse mxil-WR, the resulting chimeric construct exhibited a level of repression comparable to mouse mxil-SR (data not shown). In addition, a proline for leucine substitution at position 19 of the repressive domain of Mxi-SR (see Figure 1B ) significantly diminished suppressive activity (experiments 3, 4, and 5 in Figure 2B ); since proline residues are known to cause disruption of a-helical structures, this loss of function suggests that a helicity may be integral to amino-terminal functions. Averaged over multiple independent experiments (representative ones employing the entire panel of mxi expression constructs are shown in experiments 4 and 5 in Figure  2B ), the fold suppression induced was 5.3 for human MXl, 8.1 for mouse Mxi-SR, 1.74 for mouse Mxi-WR, 1.57 for mouse Mxi-Arep, and 1.78 for mouse Mxi-SR-pro. As these findings clearly indicated that the amino-terminal region of Mxil-SR is essential for full anti-Myc activity, its modular nature was examined further by assaying whether fusion of this domain onto Max could enhance the repressive potential of Max. We and others have demonstrated previously that inclusion of hypermolar amounts of a max expression construct in cotransfections can inment of the domains that confer repressive activity upon mouse Mxi-SR and human MXI with a similarly positioned region in the human MAD amino terminus. This repression domain is absent from the weakly repressive Mxi-WR. The ~z-helical nature of this domain, as assessed by the PredictProtein algorithm (European Molecular Biology Laboratory), results from the amphipathicity of these residues. The teucine residue (Leu-19) that was converted to a proline to make Mxi-SR-pro (discussed in Experimental Procedures) is marked by an asterisk. (Makela et al., 1992; Mukherjee et al., 1992; Prendergast et al., 1992) , whereas addition of submolar amounts of the max construct can act to enhance mycl RAS transforming potential slightly (Prendergast et al., 1992) , presumably through the increased formation of transactivation-competent Myc-Max heterocomplexes. Based on these observations, the impact of submolar amounts of two expression constructs, one encoding mouse Max and the other encoding a chimeric protein in which the repression domain of Mxil-SR was fused inframe to the bHLH-LZ and 3' ORF sequences of mouse Max (mmax-rep in Figure 2A ), was examined in the REF assay. As shown in Figure 2C , addition of small amounts of the max expression construct did not alter the average number of loci per plate, whereas addition of the same amounts of the mouse max-rep construct exerted a profound repressive effect upon Myc cotransformation activity. Notably, in multiple experiments, the level of repression seen with the addition of an equimolar amount of mxi-SR to c-myclRAS cotransfections appeared to be attained with one eighth that amount of mouse max-rep. Although the precise basis for the greatly enhanced level of repression seen with mouse max-rep remains to be determined, it may relate to the extremely stable nature of the Max protein as well as to the ability of the Max HLH-LZ region to associate with all members of Myc superfarnily (Blackwood and Eisenman, 1991; Prendergast et al., 1991; Blackwood et al., 1992; Zervos et al., 1993) . That this enhanced repressive potential could have been secondary to our deletion of Max 5' ORF sequences (including phosphorylation sites) was ruled out by the finding that a construct having Mxi-WR 5' ORF sequences appended onto the same Max 3' ORF sequences present in the mouse maxrep construct did not alter the average number of foci per plate when added in submolar amounts to myclRAS cotransfections (data not shown).
DNA t ransfect ed with
Interaction of the Repression Domain with a Mammalian Homolog of Yeast SIN3
The predicted co-helical configuration of the repressive domain of Mxi (and MAD) proteins raised the possibility that the molecular mechanisms governing biological activities of the repressive domain may be executed through protein-protein interactions. To identify proteins that associate with these repression domains, a modified version of the yeast two-hybrid method (Vojtek et al., 1993) (Devereux et al., 1984) . Between the mouse and the yeast (Wang et al., 1990; Vidal et al., 1991) SIN3 residues, vertical lines represent identity, colons represent high homology, and elipses represent weak similarity. Shown is the interacting region of mSin3, with helices of PAH2 outlined by boxes. The leucine residue in helix 1 of PAH2 that was converted to a proline to generate Sin3-pro (see Experimental Procedures) is marked by an asterisk.
et al., 1993) was fused in-frame to the LexA-DNA-binding domain (DBD), and the fusion protein encoded by this construct was used as a bait to screen for interacting fusion proteins encoded by a mouse T cell lymphoma cDNA library subcloned in the GAL4 transactivation domain (TAD)-containing pACT vector. Approximately 4 x 106 transformants were screened under selection for expression of both fusion proteins, and 11 yeast clones were identified that exhibited growth in histidine-free media and activity in a 13-galactosidase filter assay. This phenotype is consistent with an interaction between the repressive domain-LexA bait and a cellular protein-GAL4 fusion that results in transactivation of two integrated reporter constructs, the yeast HIS3 gene and the bacterial lacZ gene, each containing LexA-binding sites in their promoters. Nucleic acid sequence analysis of the T cell-derived cDNA ORFs fused in-frame with the GAL4 TAD revealed that they all were capable of encoding a mammalian protein possessing 49% similarity (33% identity) to the yeast transcriptional repressor SIN3 (Wang et al., 1990; Vidal et al., 1991) . The region of homology between mSin3 and yeast SIN3 corresponded to the region encompassing the second of four paired amphipathic heffces (PAHs) found in the yeast protein (Figure 3) . Additional nucleotide sequence analysis of partial mouse sin3 cDNA clones isolated from a mouse newborn brain cDNA library demonstrated that the high degree of amino acid homology extends well beyond the PAH2 region in both directions and includes additional PAH-homologous structures (N. S.-A. and R. A. D., unpublished data). Furthermore, screening of Southern blots of mouse and human genomic DNA with a mouse sin3 PAH2-containing probe revealed the presence of two sin3-related loci in each species (data not shown). The homolog identified in our studies corresponds to the sin3B clone presented in Ayer et al. (1995 [ 
this issue of Cell]).
To begin to assess the nature of the interaction between the repressive domain of MAD or Mxi and the PAH2 region of rosin3, we tested yeast transformants bearing various LexA-DBD and GAL4-TAD fusion proteins for activity in the 13-galactosidase filter assay. As shown in Figure 4 , a marked difference in the interaction was observed for the two mouse mxil cDNA forms as evidenced by a LacZ + phenotype for the Mxi-SR plus mSin3 transformants, but not for the Mxi-WR plus mSin3 transformants. LacZ assays of transformants with other combinations of plasmids showed that the interaction between the GAL4-mSin3 protein and a LexA bait containing either the full-length Mxi-SR or the 36 amino acid repressive domain of Mxi-SR (Mxi-SR-NT) was found to be comparable to that observed between mSin3 and the amino-terminal region of human MAD (Mad-NT in Figure 4 ). In addition, a proline for leucine substitution at position 19 in Mxi-SR (this residue is predicted to lie on the hydrophobic interface of the c~-helical repression domain; see Figure 1B ) markedly diminished ~-galactosidase activity (Mxi-SR-pro plus Sin3 in Figure  4 ). Similarly, a proline for leucine substitution in helix 1 of the mSin3 PAH2 motif (see residue marked with an asterisk in Figure 3 ) abolished the interaction with the Mxi repressive region (Mxi-SR-NT plus Sin3-pro in Figure 4 ). An unanticipated observation in these yeast studies was the finding that the LexA-Mxi-SR bait appeared incapable of interacting with GAL4-TAD-Max (data not shown). Our ability to detect the Mxi-SR-Max interaction in mammalian cells (see below), but not by the two-hybrid system in yeast, may point to deficiencies in the latter resulting from the Having shown that the repressive region of Mxil interacts specifically with the PAH2-containing domain of the mSin3 homolog when expressed in yeast, we next assessed whether this association could occur in mammalian cells. Subconfluent COS7 monolayers were cotransfected with various combinations of expression constructs encoding Mxi-SR fused at its carboxyl terminus to a Myc epitope tag, encoding the Sin3 PAH2-containing region joined to an amino-terminal hemagglutinin (HA) epitope tag, or encoding mouse Max. Whole-cell extracts were prepared from metabolically labeled transfected cultures and subjected to immunoprecipitation reactions under low or high stringency conditions (see Experimental Procedures).
As shown in Figure 5A , each of the antibodies utilized immunoprecipitated a protein of expected size (28 kDa HA-tagged Sin3, 35 kDa Myc-tagged Mxi-SR, and 21 kDa Max; lanes 4, 7, and 10), but only when the appropriate expression construct was added to the transfection (Figure 5A, lanes 1-3, 5 -6, 8-9, and 11-12) . In cotransfections, the anti-HA tag antibody immunoprecipitated Myctagged Mxi-SR when coexpressed with HA-tagged Sin3 and, conversely, the anti-Myc tag antibody immunoprecipitated HA-tagged Sin3 when cotransfected with Myctagged Mxi-SR under low and high stringency conditions ( Figure 5A , lanes 13-16; Mxi band in lane 13 is observable upon longer exposure). The Mxi-Max association, detectable only under low stringency, was shown by the appearance of the Max protein in the anti-Myc tag precipitate and by the Myc-tagged Mxi-SR protein in the anti-Max precipitate ( Figure 5A , lanes 17-18; high stringency data not shown). These low stringency conditions, which involve the use of buffers containing only nonionic detergents, were shown previously to preserve the c-MYC-MAX complex that is disrupted by the addition of SDS and deoxycholate . Most importantly, since a Max-Sin3 association fails to occur in cells doubly transfected with max and HA-tagged sin3 expression constructs ( Figure 5A, lanes 19-20) , the appearance of Sin3 in anti-Max immunoprecipitates of cells triply transfected with Myc-tagged mxi-SR, HA-tagged sin3, and max indicates that the three proteins exist in a ternary complex in vivo ( Figure 5A , lane 21; also see Figure 5B , lane 1).
Finally, to substantiate results obtained in yeast smallscale transformations (see Figure 4 ) with respect to specificity of the interaction between various Sin3 and Mxi derivatives, we assessed various mutant expression constructs for interaction by im munoprecipitation of cotransfected extracts ( Figure 5B ). These studies showed that Sin3-pro could not form a complex with Max and Mxi-SR ( Figure  5B , lane 2) and that Mxi-SR-pro could associate with Max but not with Sin3 ( Figure 5B, lanes 3-5) .
Discussion
In this study, the characterization of two mouse m x i l transcript forms has allowed us to develop a better understanding of the molecular basis of the anti-Myc actions of Mxil and of the functional interrelationships among members of the Myc superfamily. The two transcripts, arising from a single mouse m x i l gene, differ in their capacity to encode a 36 residue amino-terminal extension. By using these alternative Mxil protein forms and various mutant derivatives in a powerful and well-established assay for Myc function, we have established that this extension serves as a modular domain essential for potent anti-oncogenic activity. A key role for this region is also suggested by its high degree of structural conservation, both between phylogenetically distant Mxil proteins (Zervos et al., 1993; Schreiber-Agus et al., 1994) and with the similarly suppressive MAD protein Lahoz et al., 1994) . Although a data base homology search failed to provide any obvious clues about the function of this domain, its conserved capacity for secondary structure formation (and the need to maintain helicity for full activity; see Mxi-SR-pro in Figure 2B ) and its strong affinity for a mammalian homolog of yeast SIN3 in vivo suggest that its repressive actions may be executed through proteinprotein interactions.
Substantial structural homology between mammalian and yeast SIN3 implies conservation of functional properties as well. For the yeast protein, documented properties include nuclear localization, inability to bind DNA directly, potential to associate with other factors through four PAHs (analogous to the HLH dimerization motifs), and, finally, ability to repress transcription of a diverse set of target genes (Wang et al., 1990; Vidal et al., 1991; Wang and Stillman, 1993 , and references therein). Although yeast SIN3 also has been shown in some contexts to be involved in transcriptional activation (Vidal et al., 1991; Yoshimoto et al., 1992) , this effect is likely indirect in nature (Wang and Stillman, 1993) . With respect to mammalian Sin3, the tethering of this putative transcriptional modulator, through its PAH2 domain, to promoters of key growth genes may occur through the Mxi-Max heterodimeric complex. Once in the context of a promoter, Sin3 may exert its repressive effects by modifying the activity of other transcriptional regulators or by maintaining the surrounding chromatin in a repressed heterochromatic state (Vidal et al., 1991; Wang and Stillman, 1993 ; for review on transcriptional repressors, see Cowell, 1994) . Interactions with other transcriptional regulators or factors of the general transcription machinery could occur through the three additional PAH motifs, with Sin3 serving as a scaffold for formation of a higher order repressive complex (Wang and Stillman, 1993) .
Our observations with respect to the requirement of the amino-terminal extension for full suppressivity ( Figure 2B ) and to the formation of an Mxi-Sin3-Max ternary complex in vivo ( Figure 5 ) have prompted us to reexamine the prevailing view of how Myc activity is regulated by Mxil or Mad (for review see Amati and Land, 1994) . In the current model, regulation of Myc-responsive genes is thought to involve the titration by Mxi of a limited intraceltular pool of Max and the occupation (as an Mxi-Max heterodimer) of consensus recognition sequences in promoters of commonly regulated genes. Once bound, the transactivationincompetent Mxi-Max heterodimer could serve to deny access to the active Myc-Max complex Zervos et al., 1993; Lahoz et al., 1994;  for review see Amati and Land, 1994) . The observation that Mxi-WR possessed only modest repressive potential (despite having the identical bHLH-LZ region as Mxi-SR and thus being able to complex with Max and bind consensus sites) argues against the simple view that Mxi regulates Myc activity in such a passive manner. Rather, since the ability of a given Mxil complex to antagonize fully Myc function requires activities encoded within the amino-terminal region, Mxi-SR (as well as MAD; see Ayer et al., 1995) appears to play a more active role in negative regulation. The findings of this study lead us to speculate that this regulation is achieved through the recruitment, by the ternary complex, of specific proteins that together mediate transcriptional repression of Myc-responsive gene targets.
Comparison of steady-state mRNA expression of Mxi-SR, Mxi-WR, and Myc during embryogenesis and in newborn and adult tissues (data not shown) has provided insight into how these three proteins functionally relate one to another during development. First, in accordance with findings made in cell culture-based differentiation systems (Zervos et al., 1993) , we have observed declining levels of c-myc mRNA (as described previously by Zimmerman et al., 1986) and constant or increasing levels of mxil-SR (N. S.-A. and R. A. D., unpublished data) with progressive development and growth arrest in many organs of the mouse. This concurs with previous hypotheses stating that while proliferative processes may correlate with the activated expression of growth-promoting genes by the MycMax complex, events associated with differentiation may involve repression of genes in the same or related pathways by Mxi-Max or Mad-Max Zervos et al., 1993;  for review see Amati and Land, 1994) . Growth arrest/terminal differentiation presumably prompted by Mxi-SR may be, under specific physiological circumstances, delayed or prevented by the weakly repressive Mxi-WR. For instance, although mxi-WR levels were observed to be significantly lower than those of mxi-SR in tissues that have nearly completed their differentiation programs, transcripts of the two forms were nearly comparable in amount during the midgestational stages of embryogenesis (N. S.-A. and R. A. D., unpublished data). During this period of dwindling cellular growth but continued active differentiation, Mxi-WR may attenuate the repressive properties of Mxi-SR by competing for common target sequences, accessory proteins, or both through their shared carboxy-terminal regions.
A role for Mxi-SR in normal growth and development and in cancer pathogenesis gains support from many of the biochemical and biological features described in this study. These features include anti-Myc transformation activity (also see Lahoz et al., 1994; Schreiber-Agus et al., 1994) , interaction with a putative transcriptional repressor, reciprocal pattern of expression between mxi-SR and myc with respect to growth and differentiation (Zervos et al., 1993; Larsson et al., 1994; N. S.-A. and R. A. D., unpublished data) , and mapping to a chromosomal location (10q24-26) that is a common target for cytogenetic lesions found in several human malignancies, including melanoma, prostate cancer, glioblastoma multiforme, and leukemia/lymphoma (Edelhoff et al., 1994) . Specifically, Mxil may act as a growth suppressor whose loss of function could serve as an important event in the development of some naturally occurring human cancers. In this regard, it is intriguing that the mouse sin3 gene maps to a chromosomal position that is distinct from that of mxi (J. M. Rochelle, M. F. Seldin, and R. A. D., unpublished data) and that is highly syntenic to a human chromosomal region cytogenetically involved in tumors similar in type to those involving the MXl locus. Concordance in the tumor types associated with these two distinct loci lends additional genetic evidence that mxil and sin3 are functionally linked to each other. Finally, observations made in this study call for tumor surveys that take into account not only those lesions that disrupt the mxil or mouse sin30RF, but also those that result in a regulated switch from strongly to weakly repressive mxi transcript forms.
Experimental Procedures
Isolation of Genomic and cDNA Clones and Analysis of DNA and Putative Proteins For the isolation of mouse mxil-related sequences, three human MX/1 probes were used to screen at low stringency an amplified Mbol partial mouse genomic library in Charon 35A, an oligo(dT)-primed ;~gtl0 cDNA library generated from RNA derived from MEL cell cultures 18 hr after induction with hexamethylene bisacetamide (Cheng and Skoultchi, 1989) , and an oligo(dT)-and random-primed XZAPII cDNA library generated from RNA derived from mouse newborn brain (Stratagene). The human MXI1 probes included a 315 bp bHLH-LZencoding Pstl fragment, a 200 bp PCR-generated probe corresponding to the 5'-most region, and an 1100 bp Sspl fragmen t containing 3'UTR sequences (the human MXI1 cDNA clone was provided by R. Brent [Zervos et al., 1993] ). Purification of recombinant clones, subcloning, probe preparation and radiolabeling, and blotting and hybridizations were performed as described previously (Sambrook et al., 1989) . Nucleotide sequence was determined by Sequenase (U. S. Biochemicals) and partial chemical degradation (Maxam and Gilbert, 1980) and was analyzed with the Genetics Computer Group sequence analysis software package (Devereux et al., 1984) .
Expression Constructs and REF Cooperation Assays
Expression constructs for mouse mxil-WR and mouse mxi-SR were generated by placing their respective cDNAs in the sense orientation relative to two tandemly repeated Moloney murine leukemia virus long terminal repeats in pVNic (Schreiber-Agus et al., 1993) , a derivative of the pVcos7 vector (Yancopoulos et al., 1985) . The human MXI1 expression construct contained the 2.4 kb EcoRI cDNA insert described elsewhere (Zervos et al., 1993) subcloned into the pVcos7 vector in the sense orientation relative to the long terminal repeats (Lahoz et al., 1994) . To make the mouse mxil-Arep construct, a 120 bp PCR-generated fragment encoding mouse Mxi-SR 5'UTR and the first three codons of Mxi-SR was ligated in-frame to a 630 bp PCRgenerated fragment that encoded amino acids 34-228 of Mxi-SR; the resultant fragment (deleted for Mxi-SR amino acids 4-33) was subcloned in pVNic in the sense orientation. Mxil-SR-pre is identical to the mxil-SR expression construct except that Leu-19 was converted to a proline residue by PCR-based site-directed mutagenesis, a modification confirmed by nucleotide sequence analysis. The construct maxrep was made by ligating a 330 bp EcoRI-Bglll fragment from mxi-SR containing 5'UTR and repressive region-encoding sequences in-frame to a PCR-generated 430 bp BgllI-Sall fragment from mouse max encoding its ORF from the basic region (amino acid 16 of MaxA9) to the terminator and a 1300 bp SalI-EcoRI fragment from the mouse max 3'UTR (the template CMV-max was provided by E. Ziff); the resultant chimeric gene was subcloned into pVNic. As a control for max-rep, a 1.8 kb HindllI-EcoRI fragment of the max cDNA encoding the MaxA9 protein was subcloned into pVNic. The mouse c-myc expression construct, pKO-myc (Mukherjee et al., 1992) , contains exons 2 and 3 of the mouse c-myc genomic clone driven by a simian virus 40 promoter/ enhancer element, pT24-ras encodes the mutant H-RAS (Val-12) oncogene (Fasano et al., 1983) . Early passage cultures of REFs were prepared and cotransfected by the calcium phosphate precipitation method as described previously (Mukherjee et al., 1992) .
Yeast Two-Hybrid Screens
To identify cellular proteins that interact with the highly conserved amino-terminal repressive regions of MAD and Mxi-SR, a mouse T cell lymphoma Matchmaker cDNA library in the vector pACT (Clontech) was introduced into the Saccharomyces cerevisiae L40 reporter strain bearing the MAD-NT-LexA fusion plasmid (LexA plasmid pBMT116 was provided by R. Sternglanz; construct is described in the legend to Figure 4 ) using a modified version (Vojtek et al., 1993) of the two-hybrid system developed by Fields and Song (1989) . Standard manipulations of yeast were performed essentially as described . Transformants were plated onto synthetic media plates lacking histidine, leucine, tryptophan, uracil, and lysine and containing 25 mM 3-aminotriazole, a chemical inhibitor of imidazole glycerol phosphate dehydratase, which restores histidine auxotrophy (Durfee et al., 1993) . His + colonies were assayed for ~-galactosidase activity by a qualitative filter assay (Vojtek et aL, 1993) , and DNA isolated from transformants with the His + LacZ + phenotype was electroporated into HB101 cells on synthetic media lacking leucine. The pACT inserts were sequenced with a GAL4 TAD-specific primer (5;CTATTCGA-TGATGAAGATACCCCACC-3~. To examine interactions between various Mxi-or MAD-LexA fusion proteins and mSin3-GAL4 or mouse Max-GAL4 fusion proteins, we introduced plasmids shown in Figure 4 successively into the L40 reporter strain by small-scale transformation, and ~-galactosidase activity of the double transformants was determined by filter assay as described previously .
Immunoprecipitation COS7 cells were transfected with 5 I~g each of the appropriate expression constructs indicated in Figure 5 and 100 p.g of LipofectAMINE reagent (GIBCO BRL), allowed to grow for an additional 40 hr, and metabolically labeled using the EXPRE~S3sS protein-labeling mix (DuPont-New England Nuclear) for 4 h r. Immunoprecipitations under high and low stringency conditions were performed as described , and samples were resuspended in SDS loading buffer, analyzed on 12.5% SDS-polyacrylamide gels, and visualized by autoradiography. To generate the Myc-tagged mxi-SR construct, we subcloned the mxi-SR ORF into the pJFE14 expression vector that provides a triple Myc epitope tag (EQKLISEEDL) at the carboxyterminal end of the protein (Davis et al., 1994 ; pJFE14 was a gift from G. Yancopoulos). A similarly designed sin3 expression construct (HA-tagged sin3) encoded an amino-terminal anti-influenza HA epitope tag (YPYDVPDYA) (Cortes et al, 1994) fused to a 200 amino acid segment of mouse sin3 containing the PAH2 structure. The Myctagged Mxi-SR-pro and Sin3-pro expression constructs contained proline for leucine substitutions at positions shown in Figures 1B and 3 , respectively. CMV-max was used in the max transfections. The antiMyc tag antibody is the mouse monoclonal antibody 9E10 (Oncogene Science); the monoclonal antibody directed to the HA peptide, 12CA-5, was provided as ascites fluid through the Albert Einstein College of Medicine Cancer Center hybridoma facility (M. Scharff and S. Buhl); and the polyclonal Max antibody was aCT (a gift from E. Ziff).
